Literature DB >> 18638111

Corpus luteum-endometrium-embryo interactions in the dairy cow: underlying mechanisms and clinical relevance.

R S Robinson1, A J Hammond, D C Wathes, M G Hunter, G E Mann.   

Abstract

Conception rates of dairy cows are currently declining at an estimated 1% every year. Approximately, 35% of embryos fail to prevent luteolysis during the first three weeks of gestation. Interactions between the corpus luteum, endometrium and embryo are critical to the successful establishment of pregnancy and inadequacies will result in the mortality of the embryo. For example, as little as a one day delay in the post-ovulatory rise of progesterone has serious consequences for embryo development and survival. Recently, we found that LH support, degree of vascularization and luteal cell steroidogenic capacity were not the major factors responsible for this luteal inadequacy, but are nevertheless essential for luteal development and function. Progesterone acting on its receptor in the endometrium stimulates the production of endometrial secretions on which the free-living embryo is dependent. However, their exact composition and effects of inadequate progesterone remains to be determined. The embryo is recognized through its secretion of interferon tau (IFNT), which suppresses luteolytic pulses of prostaglandin F(2 alpha). In the cow, it is most likely that IFNT inhibits oxytocin receptor up-regulation directly and does not require the prior inhibition of oestrogen receptor alpha (ESR1). Unravelling the precise luteal-endometrium and embryo interactions is essential for us to understand pregnancy establishment and development of strategies to reverse the declining fertility of dairy cows.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638111     DOI: 10.1111/j.1439-0531.2008.01149.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  7 in total

1.  Effect of dietary n-3 polyunsaturated fatty acids on transcription factor regulation in the bovine endometrium.

Authors:  Sinéad M Waters; Gerard S Coyne; David A Kenny; Dermot G Morris
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

2.  Circulating microRNA as candidates for early embryonic viability in cattle.

Authors:  Ky G Pohler; Jonathan A Green; Laura A Moley; Sumedha Gunewardena; Wei-Ting Hung; Rebecca R Payton; Xiaoman Hong; Lane K Christenson; Tom W Geary; Michael F Smith
Journal:  Mol Reprod Dev       Date:  2017-08       Impact factor: 2.609

3.  Colony-stimulating factor 2 (CSF-2) improves development and posttransfer survival of bovine embryos produced in vitro.

Authors:  Bárbara Loureiro; Luciano Bonilla; Jeremy Block; Justin M Fear; Aline Q S Bonilla; Peter J Hansen
Journal:  Endocrinology       Date:  2009-09-24       Impact factor: 4.736

4.  Fine-tuned adaptation of embryo-endometrium pairs at implantation revealed by transcriptome analyses in Bos taurus.

Authors:  Fernando H Biase; Isabelle Hue; Sarah E Dickinson; Florence Jaffrezic; Denis Laloe; Harris A Lewin; Olivier Sandra
Journal:  PLoS Biol       Date:  2019-04-12       Impact factor: 8.029

Review 5.  A review of the causes of poor fertility in high milk producing dairy cows.

Authors:  S W Walsh; E J Williams; A C O Evans
Journal:  Anim Reprod Sci       Date:  2010-12-30       Impact factor: 2.145

6.  Histological and hemodynamic characterization of corpus luteum throughout the luteal phase in pregnant and non-pregnant buffalos in relation to nitric oxide levels based on its anatomical determination.

Authors:  Samer M Daghash; Noha A E Yasin; Elshymaa A Abdelnaby; Ibrahim A Emam; Ayman Tolba; Yara S Abouelela
Journal:  Front Vet Sci       Date:  2022-07-28

7.  Expression of nuclear progesterone receptor and progesterone receptor membrane components 1 and 2 in the oviduct of cyclic and pregnant cows during the post-ovulation period.

Authors:  Marie Saint-Dizier; Olivier Sandra; Stéphane Ployart; Martine Chebrout; Fabienne Constant
Journal:  Reprod Biol Endocrinol       Date:  2012-09-07       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.